Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that on December 16, 2024 – according to its program related to employee share bonuses – 206,546 treasury shares were granted to 4,974 employees. Until January 1, 2027 the shares will be held in deposit on the employee’s securities accounts kept by […]
Gedeon Richter Plc. and Hikma Pharmaceuticals Plc. has announced that the U.S. Food and Drug Administration (FDA) had accepted for review the Biologics License Applications (BLA) for RGB-14, a Denosumab biosimilar candidate comprising two biosimilar products referencing Prolia® and Xgeva®, a human monoclonal antibody for the treatment of osteoporosis and fractures due to bone metastasis, […]
Consolidated sales of Richter Gedeon Plc. amounted to HUF 636.4 billion in the first nine months, up 5.7% year-on-year, the pharmaceutical company announced on the website of the Budapest Stock Exchange on Tuesday. The company posted a 42.2% increase in profit after tax to 175.9 billion forints in the first three quarters. The report underlined […]
On Friday, the Budapest Stock Exchange (BSE) commemorated the 30th anniversary of the listing of the pharmaceutical giant Richter Gedeon Plc. with a ceremonial opening bell Participation on the stock market has made a significant contribution to the success of the pharmaceutical company both at home and abroad, a BSE statement to MTI said, explaining […]
The pharma companies AbbVie (headquartered in North Chicago, Illinois in the United States) and Gedeon Richter Plc. (headquartered in Budapest, Hungary) have announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions. A statement on the website of the Budapest Stock Exchange highlights that this collaboration […]
Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Gedeon Richter have reached an exclusive commercialization and license agreement for BAT2206, a biosimilar candidate to Stelara, it was announced on the website of the Budapest Stock Exchange. Under the agreement, Bio-Thera will maintain responsibility for development, manufacturing, and supply […]
The Centenary Foundation of Richter Gedeon Plc., a Budapest-based pharmaceutical company, will provide HUF 100 million in grants to public educational institutions for the development of equipment and technical conditions necessary for the teaching of natural sciences, the company told MTI on Monday. According to the statement, the foundation first published its call for the […]
The new headquarters of Richter Plc. in Kőbánya, the 10th district of the Hungarian capital was inaugurated on Thursday. The 17,400-square-meter building, which provides space for 450 employees, was completed with an investment of HUF 20 billion, financed by the pharmaceutical company from its own resources. Speaking at the opening ceremony, Energy Minister Csaba Lantos […]
The consolidated sales revenue of the pharmaceutical company Gedeon Richter Plc. was HUF 203.4 billion in the first quarter of 2024, 3.0% lower than a year earlier, the pharmaceutical company announced on the website of the Budapest Stock Exchange (BSE) on Tuesday. Analysts had expected revenues to fall 3.6% to HUF 202 billion. In the […]
The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it has submitted an offer and entered into negotiations to acquire certain assets from Mithra Pharmaceuticals SA. In the statement, Richter confirms that it has participated in the monetisation process of Mithra, which was publicly initiated by […]
A new air service will be launched between Hungary and China, so from June this year, a seventh Chinese city, Shenzhen, will be directly accessible from Budapest, with two flights a week, according to the Hungarian Ministry of Foreign Affairs and Trade. The day before, it was announced that from this summer, Xian will also […]
Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it has signed an agreement with HELM AG, a Germany-based stock corporation (“HELM”) to buy 50% stake in Richter-Helm BioTec GmbH & Co. KG (“RHT”); and 30% stake in Richter-Helm BioLogics GmbH & Co. KG. (“RHB”) to become 100% owner of […]
The Board of Directors of the Hungarian pharmaceutical company Gedeon Richter Plc. has informed the company’s shareholders in an extraordinary announcement that Erik Bogsch resigned from his position as Chairman of the Board with effect from March 1, 2024, while remaining a member of the Board. The Board of Directors accepted the resignation at its […]
The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it expanded its partnership with Mithra Pharmaceuticals SA with a binding Head of Terms (HoT) agreement for the development and commercialization of the first estetrolbased combined oral contraceptive (15 mg estetrol (E4) / 3 mg drospirenone) and […]
The Hungarian pharmaceutical company Gedeon Richter Plc. - together with Sumitomo Pharma America, Inc. and Sumitomo Pharma Switzerland, GmbH - has announced on the website of the Budapest Stock Exchange that the European Commission has granted approval of a Type II Variation application for RYEQO® (relugolix 40 mg, estradiol 1.0 mg, and norethisterone acetate 0.5 […]
